BioMarin Pharma (BMRN) says not presenting at ASH 2016 - Bloomberg
- Wall Street again marks new highs in post-election run
- Broadcom Ltd. (AVGO) Tops Q4 EPS by 11c
- Restoration Hardware (RH) Tops Q3 EPS by 4c; Guides Well Below the Street
- Unusual 11 Mid-Day Movers 12/8: (COOL) (TLRD) (DRAM) Higher; (SHIP) (OHRP) (MLSS) Lower
- Third-Party Said Interested in PrivateBancorp (PVTB) as CIBC (CM) Deal is Delayed
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
BioMarin Pharma (NASDAQ: BMRN) says not presenting at ASH 2016 - Bloomberg, citing emailed message
The company is planning to offer an update on BMN 270 at a biotech meeting in January 2017.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gabelli Starts BioMarin Pharmaceutical Inc. (BMRN) at Buy
- Horizon Pharma (HZNP) Stock Could Plateau Today After Drop - Mizuho
- Express Scripts (ESRX) puts active after negative Citron comments
Create E-mail Alert Related CategoriesFDA, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!